[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Connective Tissue Disorders |
Connective Tissue Disease; Dupuytren's Contracture; Mixed Connective Tissue Disease; PXE |
Clinical Trial: Family Intervention for Mental Illness and Substance Abuse
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to establish and evaluate a new family intervention program for individuals with mental illness and substance use disorders and their families.
| Condition | Treatment or Intervention |
|---|---|
| Mental Disorders Substance-Related Disorders Psychotic Disorders | Behavior: Family Intervention for Dual Diagnosis |
MedlinePlus related topics: Drug Abuse; Mental Health; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Family Intervention for SMI and Substance Use Disorder
Expected Total Enrollment: 140
Study start: April 2002; Expected completion: September 2007
Substance use disorder (SUD) in persons with severe mental illness may worsen the course of psychiatric illness. The loss of family support for individuals with mental illness is a major contributing factor to housing instability, homelessness, and other problems. Despite progress toward integrating mental health and substance abuse services, interventions that improve the course of mental illness while helping the families of the mentally ill are not currently available. Enhancing skills for coping with mental illness may be an effective strategy for treating SUD, decreasing caregiver burden, and improving the long-term outcomes for people with mental illness.
Patients and their families are randomly assigned to either the Family Intervention for Dual Diagnosis (FIDD) program or family psychoeducation. The FIDD program lasts for up to 3 years and includes both single and multiple-family group formats. The family psychoeducation program consists of 6 weekly sessions. Routine assessments are conducted on all patients, and relatives are evaluated on a wide range of outcomes, including substance abuse, hospitalizations, psychiatric symptoms, legal problems, aggression, housing and homelessness, family burden, social support, and quality of life. To determine the effectiveness of the FIDD program, knowledge of mental illness and problem-solving skills are assessed in the families following treatment.
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Have schizophrenia, schizoaffective disorder, or bipolar disorder
- Have a current substance use disorder (within the past 6 months)
- Are willing to have at least 4 hours of contact per week with family members or significant others
- Plan to remain in the community
- Have family members or significant others who consent to participate in the study and plan to remain in the community
Location and Contact Information
California
Pacific Clinics El Camino, Santa Fe Springs, California, 90670-3691, United States; Recruiting
Massachusetts
North Suffolk Mental Health Association, Chelsea, Massachusetts, 02150, United States; Recruiting
Kim T. Mueser, Ph.D., Principal Investigator, Dartmouth Medical School
Shirley Glynn, Ph.D., Principal Investigator, University of California, Los Angeles
More Information
Publications
Mueser KT, Fox L. A family intervention program for dual disorders. Community Ment Health J. 2002 Jun;38(3):253-70.
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: August 12, 2002
ClinicalTrials.gov Identifier: NCT00043693
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Arthritis Foundation
- ClinicalTrials.gov: Connective Tissue Diseases (National Institutes of Health)

Not Signed In -


